AHR ChIP-seq in primary human hepatocytes treated with TCDD
Ontology highlight
ABSTRACT: ChIP-seq was done on cryopreserved primary human hepatocyte with vehicle control - 0.1% dimethylsulfide (DMSO), or 1nM 2,3,7,8 tetrachlorodibezno-p-dioxin (TCDD) agonist treatment to identify AHR binding regions throughout the genome. We identified 1,984 binding peaks when comparing TCDD vs. vehicle control
ORGANISM(S): Homo sapiens
PROVIDER: GSE205502 | GEO | 2022/06/09
REPOSITORIES: GEO
ACCESS DATA